Frequently Asked Questions

Question 1

How do Aurora, Eclipse, and Tetra differ physically?

Accepted Answer

Aurora is a single-layer dehydrated amniotic membrane disc (10 mm or 12 mm) with a patent-pending 5 mm central aperture. Eclipse is a single-layer amniotic membrane allograft available in six circular diameters: 5, 8, 10, 12, 14, and 16 mm. Tetra is a single-layer dehydrated amniotic membrane in rectangular configurations (1×1 cm, 1×2 cm, 2×2 cm, and 2×3 cm). Each configuration is designed for distinct procedural contexts.

Question 2

What is Aurora's central aperture designed to do?

Accepted Answer

Aurora incorporates a central aperture designed to reduce central visual obstruction associated with membrane coverage. The aperture is 5 mm in diameter and is positioned over the central visual axis during application.

Question 3

When would a circular configuration be preferred over a rectangular one?

Accepted Answer

Circular configurations (Aurora and Eclipse) are commonly used for corneal and conjunctival applications where a round profile aligns with the anatomy of the ocular surface. Rectangular configurations (Tetra) may be considered when a broader or differently shaped coverage area is needed, including certain surgical applications. Configuration selection depends on the procedure, the defect or treatment area, and the clinician's judgment.

Question 4

Are all three products single-layer?

Accepted Answer

Yes. Aurora, Eclipse, and Tetra are each single-layer amniotic membrane products. Refer to the Instructions for Use for each product for complete specifications.

Question 5

What sterilization methods are used?

Accepted Answer

Aurora, Eclipse, and Tetra are all processed using E-Beam technique sterilization. Refer to the applicable IFU for complete processing and handling information.

Question 6

Which products are designed for office or procedural settings?

Accepted Answer

Aurora and Eclipse are designed for office-based or procedural application. Both are applied directly to the ocular surface and secured with a bandage contact lens. No surgical suite or general anesthesia is required for office-based application.

Question 7

Which product is designed for operating-room use?

Accepted Answer

Tetra, with its rectangular configurations, is designed for broader procedural and surgical applications including operating-room use. Aurora and Eclipse may also be used in procedural settings depending on the clinical context. Consult the applicable IFU for approved indications and environments.

Question 8

What is the difference between sutured and non-sutured placement?

Accepted Answer

Non-sutured placement involves positioning the membrane on the ocular surface and securing it with a bandage contact lens, without sutures. Sutured placement involves securing the membrane with sutures, which may be appropriate for certain surgical applications. The method used depends on the procedure, the product selected, and the clinician's technique.

Question 9

Can Aurora be used in the operating room?

Accepted Answer

Aurora is primarily designed for office-based and procedural application. For operating-room applications, Tetra's rectangular configurations may be more appropriate. Consult the Aurora IFU for approved indications and environments.

Question 10

What sizes does Aurora come in?

Accepted Answer

Aurora is available as 10 mm and 12 mm diameter discs, each with a 5 mm central aperture.

Question 11

How is the aperture positioned during application?

Accepted Answer

The aperture is designed to be centered over the visual axis during application. Refer to the Aurora IFU and Application Academy for detailed application technique guidance.

Question 12

Does Aurora's aperture guarantee visual function during wear?

Accepted Answer

Aurora incorporates a central aperture designed to reduce central visual obstruction associated with membrane coverage. It does not guarantee any specific level of visual acuity, visual function, or patient compliance. Clinical outcomes depend on the patient, the condition being treated, and the procedure performed.

Question 13

What is FORMULA/5™?

Accepted Answer

FORMULA/5™ is the proprietary E-Beam technique sterilization process used for Aurora, Eclipse, and Tetra. Refer to the applicable IFU for complete processing information.

Question 14

How do I order Ophthalogix products?

Accepted Answer

Ordering information is available through the Ophthalogix order page and through your Ophthalogix clinical representative. Contact the Ophthalogix team directly for current ordering procedures, pricing, and availability.

Question 15

Where can I find approved storage and handling instructions?

Accepted Answer

Complete storage and handling instructions are provided in the Instructions for Use (IFU) for each product. IFUs are available on the Downloads & IFUs page. Always follow the current IFU for the specific product and lot you are using.

Question 16

What is the shelf life of Ophthalogix products?

Accepted Answer

Aurora, Eclipse, and Tetra each have a 5-year shelf life from the date of manufacture when stored under the conditions specified in the applicable IFU. Refer to the product label and IFU for complete storage requirements.

Question 17

Are Ophthalogix products available outside the United States?

Accepted Answer

Not all products are available in all markets. Contact Ophthalogix directly for information about availability in your region.

Question 18

What is the difference between CPT 65778 and CPT 65779?

Accepted Answer

CPT 65778 concerns placement of amniotic membrane on the ocular surface without sutures. CPT 65779 concerns placement of amniotic membrane on the ocular surface with sutures. Coding depends on the procedure performed, payer requirements, documentation, and current policy — not solely on the product selected.

Question 19

Which CPT code applies to Aurora or Eclipse?

Accepted Answer

CPT code selection is determined by the procedure performed — specifically whether sutures are used — not by the product name. Aurora and Eclipse are commonly used in non-sutured office or procedural workflows, but coding must reflect the actual procedure. Consult current coding guidance and your payer before submission.

Question 20

Where can I find current reimbursement information?

Accepted Answer

Reimbursement information is available through the Reimbursement & Codes section of the Build Your Practice resources. Coding and reimbursement depend on the procedure, payer requirements, documentation, and current policy. Verify current guidance before submission.

Question 21

Does Ophthalogix guarantee reimbursement?

Accepted Answer

No. Reimbursement is determined by the payer based on the procedure performed, documentation, coverage policies, and applicable regulations. Ophthalogix provides educational coding resources only. Verify current guidance with your payer before submission.

Question 22

How do I contact clinical support?

Accepted Answer

Clinical support is available through the Ask a Clinical Question form on the Support page, or by contacting your Ophthalogix clinical representative directly. The Ophthalogix clinical team can assist with application technique, product selection questions, and practice integration.

Question 23

What educational resources does Ophthalogix provide?

Accepted Answer

Ophthalogix provides the Application Academy, Case Library, Monday Clinical Pearls, Best Practices guides, instructional videos, and downloadable IFUs. These resources are available through the Education section of the site.

Question 24

Where can I find application technique guidance?

Accepted Answer

Application technique guidance is available through the Application Academy and the Downloads & IFUs page. For procedure-specific questions, contact the Ophthalogix clinical support team.

Question 25

Can I request a clinical consultation before my first case?

Accepted Answer

Yes. The Ophthalogix clinical team is available to support clinicians before, during, and after their first application. Use the Ask a Clinical Question form or contact your representative to arrange support.

Question 26

Is the Ocular Surface Forum currently available?

Accepted Answer

The Ocular Surface Forum is currently in development. Access will require verified clinician credentials, authentication, moderation, and appropriate privacy controls. Details will be announced when the forum is ready for clinical use.

Question 27

Who will be able to access the forum?

Accepted Answer

The forum is intended for licensed eye care professionals. Verified clinician access, appropriate terms of use, and privacy safeguards will be required. Details forthcoming.

Question 28

How will I be notified when the forum launches?

Accepted Answer

Contact Ophthalogix through the Support or Contact pages to be added to the notification list for forum launch updates.

Product Configurations

Application Environments

Aurora and the Central Aperture

Ordering, Storage, and Handling

Coding and Reimbursement Resources

Clinical Education and Support

Ocular Surface Forum

Ask the Clinical Team Directly